GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Catalyst Pharmaceuticals Inc (FRA:CN2) » Definitions » Cyclically Adjusted Book per Share

Catalyst Pharmaceuticals (FRA:CN2) Cyclically Adjusted Book per Share : €1.57 (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Catalyst Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Catalyst Pharmaceuticals's adjusted book value per share for the three months ended in Sep. 2024 was €4.993. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.57 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Catalyst Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 33.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 33.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 25.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 7.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Catalyst Pharmaceuticals was 33.00% per year. The lowest was -8.20% per year. And the median was 3.55% per year.

As of today (2024-12-15), Catalyst Pharmaceuticals's current stock price is €20.10. Catalyst Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 was €1.57. Catalyst Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 12.80.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Catalyst Pharmaceuticals was 19.49. The lowest was 4.79. And the median was 9.47.


Catalyst Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Catalyst Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catalyst Pharmaceuticals Cyclically Adjusted Book per Share Chart

Catalyst Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.49 0.75 0.98 1.29

Catalyst Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 1.29 1.45 1.49 1.57

Competitive Comparison of Catalyst Pharmaceuticals's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Catalyst Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Catalyst Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Catalyst Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Catalyst Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Catalyst Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Catalyst Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book= Book Value per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=4.993/133.0289*133.0289
=4.993

Current CPI (Sep. 2024) = 133.0289.

Catalyst Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201412 0.414 99.070 0.556
201503 0.751 99.621 1.003
201506 0.681 100.684 0.900
201509 0.653 100.392 0.865
201512 0.615 99.792 0.820
201603 0.548 100.470 0.726
201606 0.498 101.688 0.651
201609 0.461 101.861 0.602
201612 0.449 101.863 0.586
201703 0.395 102.862 0.511
201706 0.358 103.349 0.461
201709 0.312 104.136 0.399
201712 0.667 104.011 0.853
201803 0.603 105.290 0.762
201806 0.593 106.317 0.742
201809 0.535 106.507 0.668
201812 0.434 105.998 0.545
201903 0.441 107.251 0.547
201906 0.544 108.070 0.670
201909 0.687 108.329 0.844
201912 0.763 108.420 0.936
202003 0.872 108.902 1.065
202006 0.955 108.767 1.168
202009 1.283 109.815 1.554
202012 1.343 109.897 1.626
202103 1.446 111.754 1.721
202106 1.520 114.631 1.764
202109 1.637 115.734 1.882
202112 1.777 117.630 2.010
202203 1.942 121.301 2.130
202206 2.221 125.017 2.363
202209 2.621 125.227 2.784
202212 2.694 125.222 2.862
202303 2.942 127.348 3.073
202306 3.253 128.729 3.362
202309 3.064 129.860 3.139
202312 3.320 129.419 3.413
202403 4.376 131.776 4.418
202406 4.771 132.554 4.788
202409 4.993 133.029 4.993

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Catalyst Pharmaceuticals  (FRA:CN2) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Catalyst Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=20.10/1.57
=12.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Catalyst Pharmaceuticals was 19.49. The lowest was 4.79. And the median was 9.47.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Catalyst Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Catalyst Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Catalyst Pharmaceuticals Business Description

Traded in Other Exchanges
Address
355 Alhambra Circle, Suite 801, Coral Gables, FL, USA, 33134
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

Catalyst Pharmaceuticals Headlines

No Headlines